131I Activity in Shower Water of Radioiodine Therapy Patients with Benign and Malignant Thyroid Diseases

被引：0
|
作者：
Happel, C. [1 ]
Faengewisch, G. L. [2 ]
Kranert, W. T. [1 ]
Gruenwald, F. [1 ]
机构：
[1] Hosp Johann Wolfgang Goethe Univ, Dept Nucl Med, Frankfurt, Germany
[2] Hosp Univ Giessen & Marburg, Dept Nucl Med, Giessen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S464 / S464
页数：1
相关论文
共 50 条
  • [31] Thyroid cancer radiotheragnostics: the case for activity adjusted 131I therapy
    Avram, Anca M.
    Dewaraja, Yuni K.
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (05) : 335 - 346
  • [32] THERAPY OF PROGRESSIVE MALIGNANT EXOPHTHALMOS WITH 131I
    CALLEJAS, RF
    AZUARA, NJA
    SALAZAR, HEO
    DETOBON, LC
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1969, 10 (06) : 390 - &
  • [33] Low-Activity 124I-PET/Low-Dose CT Versus 131I Probe Measurements in Pretherapy Assessment of Radioiodine Uptake in Benign Thyroid Diseases
    Westphal, Julian G.
    Winkens, Thomas
    Kuehnel, Christian
    Freesmeyer, Martin
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (06): : 2138 - 2145
  • [34] Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy
    Barquero, R.
    Basurto, F.
    Vega-Carrillo, H. R.
    Iniguez, M. P.
    Ferrer, N.
    Esteban, R.
    [J]. HEALTH PHYSICS, 2008, 95 (02): : 227 - 233
  • [35] Diagnostic 121I and 131I activities and radioiodine therapy -: Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma
    Meller, B
    von Hof, K
    Genina, E
    Deisting, W
    Meller, J
    Richter, E
    Baehre, M
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (06): : 243 - 248
  • [36] 131I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies
    Verburg, F. A.
    Luster, M.
    Lassmann, M.
    Reiners, C.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (03): : 93 - 99
  • [37] Teff and thyroid remnants/blood activity ratio upon 131I therapy of patients with differentiated thyroid cancer
    Kozak, OV
    Chebotareva, ED
    Sinuta, BF
    Shishkina, VV
    [J]. EXPERIMENTAL ONCOLOGY, 2001, 23 (01): : 71 - 72
  • [38] Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma
    Lam, MGEH
    Lips, CJM
    Jager, PL
    Dullaart, RPF
    Lentjes, EGWM
    van Rijk, PP
    de Klerk, JMH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10): : 5888 - 5895
  • [39] Selecting prescribed activity of 131I therapy for pediatric patients
    Glister, Owen
    Kulkarni, Kanchan
    Van Nostrand, Douglas
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [40] Population exposure-response model of 131I in patients with benign thyroid disease
    Vucenovic, Valentina Topic
    Rajkovaca, Zvezdana
    Jelic, Dijana
    Stanimirovic, Dragi
    Mikov, Momir
    Miljkovic, Branislava
    Vucicevic, Katarina
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 165
12345